{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T18:09:22Z","timestamp":1778522962385,"version":"3.51.4"},"reference-count":31,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2004,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Penicillin resistance threatens the treatment of pneumococcal infections. We used sentinel hospital surveillance (1978 to 2001) and population-based surveillance (1995 to 2001) in seven states in the Active Bacterial Core surveillance of the Emerging Infections Program Network to document the emergence in the United States of invasive pneumococcal isolates with very-high-level penicillin resistance (MIC \u2265 8 \u03bcg\/ml). Very-high-level penicillin resistance was first detected in 1995 in multiple pneumococcal serotypes in three regions of the United States. The prevalence increased from 0.56% (14 of 2,507) of isolates in 1995 to 0.87% in 2001 (\n            <jats:italic>P<\/jats:italic>\n            = 0.03), with peaks in 1996 and 2000 associated with epidemics in Georgia and Maryland. For a majority of the strains the MICs of amoxicillin (91%), cefuroxime (100%), and cefotaxime (68%), were \u22658 \u03bcg\/ml and all were resistant to at least one other drug class. Pneumonia (50%) and bacteremia (36%) were the most common clinical presentations. Factors associated with very highly resistant infections included residence in Tennessee, age of &lt;5 or \u226565 years, and resistance to at least three drug classes. Hospitalization and case fatality rates were not higher than those of other pneumococcal infection patients; length of hospital stay was longer, controlling for age. Among the strains from 2000 and 2001, 39% were related to Tennessee\n            <jats:sup>23F<\/jats:sup>\n            -4 and 35% were related to England\n            <jats:sup>14-<\/jats:sup>\n            9. After the introduction of the pneumococcal conjugate vaccine, the incidence of highly penicillin resistant infections decreased by 50% among children &lt;5 years of age. The emergence, clonality, and association of very-high-level penicillin resistance with multiple drug resistance requires further monitoring and highlights the need for novel agents active against the pneumococcus.\n          <\/jats:p>","DOI":"10.1128\/aac.48.8.3016-3023.2004","type":"journal-article","created":{"date-parts":[[2004,7,23]],"date-time":"2004-07-23T18:45:20Z","timestamp":1090608320000},"page":"3016-3023","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":84,"title":["Emergence of\n            <i>Streptococcus pneumoniae<\/i>\n            with Very-High-Level Resistance to Penicillin"],"prefix":"10.1128","volume":"48","author":[{"given":"Stephanie J.","family":"Schrag","sequence":"first","affiliation":[{"name":"Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesley","family":"McGee","sequence":"additional","affiliation":[{"name":"Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention"},{"name":"Department of International Health, Rollins School of Public Health, and Division of Infectious Diseases, School of Medicine, Emory University, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia G.","family":"Whitney","sequence":"additional","affiliation":[{"name":"Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Beall","sequence":"additional","affiliation":[{"name":"Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen S.","family":"Craig","sequence":"additional","affiliation":[{"name":"Tennessee Department of Health, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam E.","family":"Choate","sequence":"additional","affiliation":[{"name":"Department of International Health, Rollins School of Public Health, and Division of Infectious Diseases, School of Medicine, Emory University, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James H.","family":"Jorgensen","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Texas Health Science Center at San Antonio, San Antonio, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard R.","family":"Facklam","sequence":"additional","affiliation":[{"name":"Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith P.","family":"Klugman","sequence":"additional","affiliation":[{"name":"Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention"},{"name":"Department of International Health, Rollins School of Public Health, and Division of Infectious Diseases, School of Medicine, Emory University, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510470035031"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/174.5.986"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199907223410403"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.6.1306"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199611000-00010"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1097\/00006454-200005001-00009","volume":"19","year":"2000","unstructured":"Dagan, R., E. Leibovitz, A. Leiberman, and P. Yagupsky. 2000. Clinical significance of antibiotic resistance in acute otitis media and implication of antibiotic treatment on carriage and spread of resistant organisms. Pediatr. Infect. Dis. J.19:S57-S65.","journal-title":"Pediatr. Infect. Dis. J."},{"key":"e_1_3_2_8_2","first-page":"1480","volume":"4","year":"1999","unstructured":"Doit, C., C. Loukil, F. Fitoussi, P. Geslin, and E. Bingen. 1999. Emergence in France of multiple clones of clinical Streptococcus pneumoniae isolates with high-level resistance to amoxicillin. Antimicrob. Agents Chemother.4:1480-1483.","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_2_9_2","first-page":"1","volume":"18","year":"1999","unstructured":"Dowell, S. F., J. C. Butler, G. S. Giebink, M. R. Jacobs, D. Jernigan, D. M. Musher, A. Rakowsky, and B. Schwartz. 1999. Acute otitis media: management and surveillance in an era of pneumococcal resistance-a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr. Infect. Dis. J.18:1-9.","journal-title":"Pediatr. Infect. Dis. J."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-144-11-3049"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.90.2.223"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.9.4194-4216.2003"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.34.4.853-859.1996"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S1201-9712(00)90112-7","volume":"4","year":"2000","unstructured":"Huebner, R. E., A. D. Wasas, and K. P. Klugman. 2000. Trends in antimicrobial resistance and serotype distribution of blood and cerebrospinal fluid isolates of Streptococcus pneumoniae in South Africa, 1991-1998. Int. J. Infect. Dis.4:214-218.","journal-title":"Int. J. Infect. Dis."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197810052991402"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.11.4.628"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/00006454-200104000-00005","volume":"20","year":"2001","unstructured":"Kaplan, S. L., E. O. Mason, W. J. Barson, T. Q. Tan, G. E. Schutze, H. S. Bradley, L. B. Givner, K. S. Kim, R. Yogev, and E. R. Wald. 2001. Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriaxone in children treated with beta-lactam antibiotics. Pediatr. Infect. Dis. J.20:392-396.","journal-title":"Pediatr. Infect. Dis. J."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.10.3155-3160.2003"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)91527-F"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.31.10.2724-2728.1993"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.2002.03173.x"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.10.2282"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.39.7.2565-2571.2001"},{"key":"e_1_3_2_24_2","unstructured":"National Committee for Clinical Laboratory Standards. 2003. Performance standards for antimicrobial susceptibility testing. Thirteenth informational supplement M100-S13. National Committee for Clinical Laboratory Standards Wayne Pa."},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.9.2850-2858.2003"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(02)01162-2"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1098\/rspb.1997.0178"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/infdis\/153.1.78","volume":"153","year":"1986","unstructured":"Simberkoff, M. S., M. Lukaszewski, A. Cross, M. Al-Ibrahim, A. L. Baltch, R. P. Smith, P. J. Geiseler, J. Nadler, and A. S. Richmond. 1986. Antibiotic-resistant isolates of Streptococcus pneumoniae from clinical specimens: a cluster of serotype 19A organisms in Brooklyn, New York. J. Infect. Dis.153:78-82.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1089\/107662900419401"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/163.6.1273"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1086\/520209"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200012283432603"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.48.8.3016-3023.2004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.48.8.3016-3023.2004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T18:27:03Z","timestamp":1645468023000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.48.8.3016-3023.2004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["10.1128\/AAC.48.8.3016-3023.2004"],"URL":"https:\/\/doi.org\/10.1128\/aac.48.8.3016-3023.2004","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8]]},"assertion":[{"value":"2004-01-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-04-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-08-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}